QUETIAPINE FUMARATE | A204203 | LUPIN LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
ASTRAZENECA PHARMACEUTICALS LP et al v. LUPIN LTD et al 1 patentANDA 204203quetiapine fumarate | D.N.J. | 2012-11-05 | Terminated 2013-04-15 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.3335
per ea
Lowest NADAC/Unit
$0.1149
per ea
Brand NDCs
0
Generic NDCs
10
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00904680561QUETIAPINE ER 400 MG TABLET | $0.3335 | EA | Generic | — | 2026-06-17 |
| 68180061607QUETIAPINE ER 400 MG TABLET | $0.3335 | EA | Generic | — | 2026-06-17 |
| 68180061507QUETIAPINE ER 300 MG TABLET | $0.2672 | EA | Generic | — | 2026-06-17 |
| 00904680461QUETIAPINE ER 300 MG TABLET | $0.2672 | EA | Generic | — | 2026-06-17 |
| 68180061407QUETIAPINE ER 200 MG TABLET | $0.2108 | EA | Generic | — | 2026-06-17 |
| 00904680361QUETIAPINE ER 200 MG TABLET | $0.2108 | EA | Generic | — | 2026-06-17 |
Showing 6 of 10 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.